Location History:
- Lohmar, DE (2002 - 2008)
- Woergl-Angerberg, AT (2008)
Company Filing History:
Years Active: 2002-2008
Title: Tanja Ligensa: Innovator in Cancer Detection
Introduction
Tanja Ligensa is a prominent inventor based in Lohmar, Germany. She has made significant contributions to the field of cancer detection, holding a total of 5 patents. Her work focuses on innovative methods for identifying cancer cells, which can lead to improved diagnostic and therapeutic strategies.
Latest Patents
Among her latest patents, Tanja has developed methods for detecting cancer cells by using nucleic acid encoding for IGF-1 receptor interacting proteins. This invention relates to a method for the detection of tumor cell proliferation, specifically utilizing nucleic acids (SEQ ID NO:1) that encode IIP-1. Additionally, she has patented a nucleic acid molecule with the sequence SEQ ID NO:5 and its complementary sequence, which is used in both diagnosis and therapy. This nucleic acid molecule, known as IIP-10, encodes an IGF-1 receptor binding polypeptide.
Career Highlights
Tanja Ligensa is currently associated with Hoffmann-La Roche Inc., where she continues to advance her research in cancer detection technologies. Her innovative approaches have the potential to significantly impact the medical field, particularly in oncology.
Collaborations
Tanja has collaborated with notable colleagues, including Ralf Schumacher and Michael Weidner. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking technologies in cancer research.
Conclusion
Tanja Ligensa is a trailblazer in the field of cancer detection, with a strong portfolio of patents that reflect her dedication to improving diagnostic methods. Her work not only showcases her innovative spirit but also holds promise for future advancements in cancer therapy.